Parent - only financial statements (Tables) - Parent Company

12 Months Ended

Dec. 31, 2021

NANO LABS LTD

CONDENSED BALANCE SHEETS

(all amounts in RMB and US$, except number of shares or as otherwise noted)


	As of December 31,
	2021			2022
	RMB			RMB			US$
ASSETS/(LIABILITIES)
Cash and cash equivalents		88,571			25,769			3,700
Short-term investments		31,878,500			—			—
Prepayments		374,120			—			—
Due from intercompany		168,505,129			380,321,338			54,607,780
Investment in subsidiaries		(225,380,481	)		(215,932,707	)		(31,004,323	)
Other payables		(127,514	)		—			—
TOTAL ASSETS (LIABILITIES)		(24,661,675	)		164,414,400			23,607,157
SHAREHOLDERS’ EQUITY (DEFICIT)
Shareholders’ equity (deficit):
Ordinary shares ($0.0001 par value; 500,000,000 and 200,000,000 shares authorized as of December 31, 2021 and December 31, 2022, respectively; 103,790,000 and nil shares issued and outstanding as of December 31, 2021 and December 31, 2022, respectively)		66,970			—			—
Class A ordinary shares ($0.0001 par value; 242,821,846 shares authorized; nil and 54,318,514 shares issued and outstanding as of December 31, 2021 and December 31, 2022, respectively)		—			35,425			5,086
Class B ordinary shares ($0.0001 par value; 57,178,154 shares authorized; nil and 57,178,154 shares issued and outstanding as of December 31, 2021 and December 31, 2022, respectively)		—			36,894			5,297
Additional paid-in capital		201,418,380			354,803,564			50,943,854
Accumulated deficit		(223,679,698	)		(199,207,921	)		(28,602,923	)
Statutory reserves		—			6,647,109			954,414
Accumulated other comprehensive income (loss)		(2,467,327	)		2,099,329			301,429
TOTAL NANO LABS LTD SHAREHOLDERS’ EQUITY (DEFICIT)		(24,661,675	)		164,414,400			23,607,157

NANO LABS LTD

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(all amounts in RMB and US$, except number of shares or as otherwise noted)


	For the years ended December 31,
	2020			2021			2022
	RMB			RMB			RMB			US$
Net revenues		—			—			—			—
Operating expenses:
Selling and marketing expenses		—			980			—			—
General and administrative expenses		—			306,775			5,822,906			836,072
Total operating expenses		—			307,755			5,822,906			836,072
Loss from operations		—			(307,755	)		(5,822,906	)		(836,072	)
Finance income		—			—			66,144			9,497
Investment income		—			—			53,809			7,726
Income (loss) from investment in subsidiaries		(37,704,077	)		(174,636,729	)		36,821,839			5,287,000
Net income (loss) attributable to Nano Labs Ltd		(37,704,077	)		(174,944,484	)		31,118,886			4,468,151
Comprehensive income (loss):
Net income (loss)		(37,704,077	)		(174,944,484	)		31,118,886			4,468,151
Other comprehensive income (loss)
Foreign currency translation adjustment		—			(2,467,327	)		4,566,656			655,695
Total comprehensive income (loss) attributable to Nano Labs Ltd		(37,704,077	)		(177,411,811	)		35,685,542			5,123,846

NANO LABS LTD

CONDENSED STATEMENTS OF CASH FLOWS

(all amounts in RMB and US$, except number of shares or as otherwise noted)


	For the years ended December 31,
	2020		2021			2022
	RMB		RMB			RMB			US$
Net cash provided by (used in) operating activities		—		(535,017	)		3,911,561			561,635
Net cash used in investing activities		—		(201,554,446	)		(155,900,936	)		(22,384,765	)
Net cash provided by financing activities		—		201,251,124			144,043,186			20,682,191
Effect of exchange rate changes on cash and cash equivalents		—		926,910			7,883,387			1,131,921
Net increase (decrease) in cash and cash equivalents		—		88,571			(62,802	)		(9,018	)
Cash and cash equivalents at beginning of the year		—		—			88,571			12,718
Cash and cash equivalents at end of the year		—		88,571			25,769			3,700